Metoprolol tartrate is a Small Molecule owned by AstraZeneca, and is involved in 3 clinical trials, which were completed.

Metoprolol is a cardioselective competitive beta-1 adrenergic receptor antagonist with antihypertensive properties and devoid of intrinsic sympathomimetic activity. Metoprolol antagonizes beta 1-adrenergic receptors in the myocardium, thereby reducing the rate and force of myocardial contraction, and consequently a diminished cardiac output.

The revenue for Metoprolol tartrate is expected to reach a total of $1.7bn through 2038. This change impacts the valuation of this asset and is an important factor to understand the current value of the drug in a clinical process. View the complete picture with the Metoprolol tartrate NPV Report.

Metoprolol tartrate is currently owned by AstraZeneca. Recordati is the other company associated in development or marketing of Metoprolol tartrate.

Metoprolol tartrate Overview

Metoprolol Tartrate (Betaloc, Seloken, Beloken, Beloc) is an antiarrhythmic agent. It is formulated as injectable solution for intravenous route, tablet and hard gealtin capsules for oral route of administration. Metoprolol Tartrate is indicated in the treatment of for myocardial ischemia, tachycardia, post myocardial infraction, reduce cardiovascular risk factors, arrhythmias, essential hypertension, hypertension, angina pectoris prophylaxis, suspected or definite myocardial infarction, migraine prophylaxis, symptomatic treatment of hyperthyroidism and to treat disturbances of cardiac rhythm, in particular supraventricular  tachyarrhythmias.

Recordati Overview

Recordati, a subsidiary of Fimei SpA, is a pharmaceutical company that researches, develops, manufactures and markets pharmaceuticals. The company offers pharmaceuticals for cardiovascular diseases, central nervous system disorders, dermatology, musculoskeletal disorders and analgesia, and urology diseases. It also offers cosmetics, dietary supplements, pregnancy test products, over-the-counter (OTC) and non-prescription pharmaceuticals, anti-infectives and others. It manufactures pharmaceutical chemicals such as active pharmaceutical ingredients (APIs) and intermediates. The company sells its pharmaceuticals directly in the countries of its operations and through licensees in other places. Recordati is headquartered in Milan, Italy.

The company reported revenues of (Euro) EUR1,580.1 million for the fiscal year ended December 2021 (FY2021), an increase of 9.1% over FY2020. In FY2021, the company’s operating margin was 31%, compared to an operating margin of 32.4% in FY2020. In FY2021, the company recorded a net margin of 24.4%, compared to a net margin of 24.5% in FY2020. The company reported revenues of EUR485.1 million for the third quarter ended September 2022, an increase of 2.5% over the previous quarter.

Quick View – Metoprolol tartrate

Report Segments
  • Innovator (Non-NME)
Drug Name
  • Metoprolol tartrate
Administration Pathway
  • Intravenous
  • Oral
Therapeutic Areas
  • Cardiovascular
  • Central Nervous System
Key Companies
Highest Development Stage
  • Marketed

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

To create this model, GlobalData takes into account factors including patent law, known and projected regulatory approval processes, cash flows, potential applicable patients, drug margins, company expenses, and pricing estimates. Combining these data points with GlobalData’s world class analysis creates high value models that companies can use to help in evaluation processes for each drug or company.

The rNPV method integrates the probability of a drug reaching a clinical stage into the cash flow at that time, which provides a more accurate rNPV, as it considers the probability that the drug never makes it through the clinical pathway to commercialization. GlobalData’s rNPV model uses proprietary likelihood of approval (LoA)and phase transition success rate(PTSR) data for the indication in the highest development stage, which can be found on GlobalData’s Pharmaceutical Intelligence Center.